Literature DB >> 4005716

Lipid profiles of Aspergillus niger and its unsaturated fatty acid auxotroph, UFA2.

P Chattopadhyay, S K Banerjee, K Sen, P Chakrabarti.   

Abstract

A comparative study of the mycelial lipid composition of a wild strain (V35) and one unsaturated fatty acid auxotroph (UFA2) of Aspergillus niger has been performed. The lipid composition of both strains are qualitatively the same but quantitatively different. All the strains contain the following phospholipids: cardiolipin, phosphatidylethanolamine, phosphatidylcholine, lysophosphatidylethanolamine, lysophosphatidylcholine, and phosphatidylserine; and triglycerides, diglycerides, monoglycerides, ergosterol, and sterol esters as the neutral lipids; mono- and di-galactosyl diglyceride as the major glycolipids along with small amounts of the corresponding mannose analogs. Phosphatidylethanolamine and phosphatidylcholine constitute the bulk of the phospholipids. The mutant (UFA2) contains a higher level of glycerides and lower levels of sterol (both free and esterified form), phospholipids, and glycolipids than the wild type. Aspergillus niger contains C16 to C18 saturated and unsaturated fatty acids. Small amounts of long-chain (C20 to C24) and short-chain (C10 to C14) saturated and unsaturated acids are also present. Linoleic, oleic, and palmitic are the major acids, stearic and linolenic acids being minor ones. UFA2 grows only in the presence of unsaturated fatty acid (C16 or C18) and accumulates a higher concentration of supplemented acid which influences its fatty acid profile.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4005716     DOI: 10.1139/m85-067

Source DB:  PubMed          Journal:  Can J Microbiol        ISSN: 0008-4166            Impact factor:   2.419


  9 in total

1.  Characterization of Aspergillus niger siderophore that mediates bioleaching of rare earth elements from phosphorites.

Authors:  Yehia Osman; Ahmed Gebreil; Amr M Mowafy; Tarek I Anan; Samar M Hamed
Journal:  World J Microbiol Biotechnol       Date:  2019-06-11       Impact factor: 3.312

2.  Aspergillus fumigatus complement inhibitor: production, characterization, and purification by hydrophobic interaction and thin-layer chromatography.

Authors:  R G Washburn; D J DeHart; D E Agwu; B J Bryant-Varela; N C Julian
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

3.  Lipid accumulation by a cellulolytic strain of Aspergillus niger.

Authors:  A Singh
Journal:  Experientia       Date:  1992-03-15

4.  Identification of enzymes and quantification of metabolic fluxes in the wild type and in a recombinant aspergillus oryzae strain

Authors: 
Journal:  Appl Environ Microbiol       Date:  1999-01       Impact factor: 4.792

5.  Effect of essential oil of Hyssopus officinalis on the lipid composition of Aspergillus fumigatus.

Authors:  B Ghfir; J L Fonvieille; Y Koulali; R Ecalle; R Dargent
Journal:  Mycopathologia       Date:  1994-06       Impact factor: 2.574

Review 6.  Review of methods applicable to the assessment of mold exposure to children.

Authors:  H K Dillon; J D Miller; W G Sorenson; J Douwes; R R Jacobs
Journal:  Environ Health Perspect       Date:  1999-06       Impact factor: 9.031

7.  A Histoplasma capsulatum Lipid Metabolic Map Identifies Antifungal Targets.

Authors:  Daniel Zamith-Miranda; Heino M Heyman; Meagan C Burnet; Sneha P Couvillion; Xueyun Zheng; Nathalie Munoz; William C Nelson; Jennifer E Kyle; Erika M Zink; Karl K Weitz; Kent J Bloodsworth; Geremy Clair; Jeremy D Zucker; Jeremy R Teuton; Samuel H Payne; Young-Mo Kim; Morayma Reyes Gil; Erin S Baker; Erin L Bredeweg; Joshua D Nosanchuk; Ernesto S Nakayasu
Journal:  mBio       Date:  2021-11-23       Impact factor: 7.867

8.  Metabolic model integration of the bibliome, genome, metabolome and reactome of Aspergillus niger.

Authors:  Mikael Rørdam Andersen; Michael Lynge Nielsen; Jens Nielsen
Journal:  Mol Syst Biol       Date:  2008-03-25       Impact factor: 11.429

9.  Analysis of Aspergillus nidulans metabolism at the genome-scale.

Authors:  Helga David; Ilknur S Ozçelik; Gerald Hofmann; Jens Nielsen
Journal:  BMC Genomics       Date:  2008-04-11       Impact factor: 3.969

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.